Literature DB >> 12172212

Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations.

Kun Tang1, Soo-Mun Ngoi, Pai-Chung Gwee, John M Z Chua, Edmund J D Lee, Samuel S Chong, Caroline G L Lee.   

Abstract

The MDR1 multidrug transporter plays a key role in determining drug bioavailability, and differences in drug response exist amongst different ethnic groups. Numerous studies have identified an association between the MDR1 single nucleotide polymorphism (SNP) exon 26 3435C>T and differences in MDR1 function. We performed a haplotype analysis of the MDR1 gene in three major ethnic groups (Chinese, Malays and Indians) by examining 10 intragenic SNPs. Four were polymorphic in all three ethnic groups: one occurring in the non-coding region and three occurring in coding exons. All three coding SNPs (exon 12 1236C>T, exon 21 2677G>T/A and exon 26 3435C>T) were present in high frequency in each ethnic group, and the derived haplotype profiles exhibited distinct differences between the groups. Fewer haplotypes were observed in the Malays (n = 6) compared to the Chinese (n = 10) and Indians (n = 9). Three major haplotypes (> 10% frequency) were observed in the Malays and Chinese; of these, two were observed in the Indians. Strong linkage disequilibrium (LD) was detected between the three SNPs in all three ethnic groups. The strongest LD was present in the Chinese, followed by Indians and Malays, with the corresponding LD blocks estimated to be approximately 80 kb, 60 kb and 40 kb, respectively. These data strongly support the hypothesis that strong LD between the neutral SNP exon 26 3435C>T and a nearby unobserved causal SNP underlies the observed associations between the neutral SNP and MDR1 functional differences. Furthermore, strong LD between exon 26 3435T and different unobserved causal SNPs in different study populations may provide a plausible explanation for conflicting reports associating the same exon 26 3435T allele with different MDR1 functional changes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12172212     DOI: 10.1097/00008571-200208000-00004

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  77 in total

1.  Detection of MDR1 single nucleotide polymorphisms C3435T and G2677T using real-time polymerase chain reaction: MDR1 single nucleotide polymorphism genotyping assay.

Authors:  Pengfei Song; Shen Li; Bernd Meibohm; A Osama Gaber; Marsha R Honaker; Malak Kotb; Charles R Yates
Journal:  AAPS PharmSci       Date:  2002

2.  Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene.

Authors:  Nicole Soranzo; Gianpiero L Cavalleri; Michael E Weale; Nicholas W Wood; Chantal Depondt; Richard Marguerie; Sanjay M Sisodiya; David B Goldstein
Journal:  Genome Res       Date:  2004-06-14       Impact factor: 9.043

3.  Inference from the relationships between linkage disequilibrium and allele frequency distributions of 240 candidate SNPs in 109 drug-related genes in four Asian populations.

Authors:  Pei-Chieng Cha; Ryo Yamada; Akihiro Sekine; Yusuke Nakamura; Chong-Lek Koh
Journal:  J Hum Genet       Date:  2004-09-11       Impact factor: 3.172

4.  No association between MDR1 (ABCB1) 2677G>T and 3435C>T polymorphism and sporadic colorectal cancer among Bulgarian patients.

Authors:  Darinka Todorova Petrova; Petya Nedeva; Svilen Maslyankov; Svetoslav Toshev; Nikolay Yaramov; Srebrena Atanasova; Draga Toncheva; Michael Oellerich; Nicolas von Ahsen
Journal:  J Cancer Res Clin Oncol       Date:  2007-08-03       Impact factor: 4.553

5.  Detection of C1236T, G2677T/A, and C3435T polymorphism of MDR1 by amplification refractory mutation system PCR.

Authors:  Bing Chen; Jie Fang; Weixia Zhang; Zhao Jin; Zichen Yu; Weimin Cai
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

6.  MDR1 genotypes do not influence the absorption of a single oral dose of 600 mg valacyclovir in healthy Chinese Han ethnic males.

Authors:  Yan Zhang; Xue-Hua Jiang; Yu-Qin Hu; Zhi-Ru Li; Lan Su; Zhan-Guo Wang; Guo Ma
Journal:  Br J Clin Pharmacol       Date:  2008-05-06       Impact factor: 4.335

7.  Using population mixtures to optimize the utility of genomic databases: linkage disequilibrium and association study design in India.

Authors:  T J Pemberton; M Jakobsson; D F Conrad; G Coop; J D Wall; J K Pritchard; P I Patel; N A Rosenberg
Journal:  Ann Hum Genet       Date:  2007-05-30       Impact factor: 1.670

Review 8.  Pharmacogenomics in colorectal cancer: the first step for individualized-therapy.

Authors:  Eva Bandrés; Ruth Zárate; Natalia Ramirez; Ana Abajo; Nerea Bitarte; Jesus Garíia-Foncillas
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

9.  Effect of MDR1 C3435T polymorphism on lansoprazole in healthy Japanese subjects.

Authors:  Chise Kodaira; Mitsushige Sugimoto; Masafumi Nishino; Mihoko Yamade; Naohito Shirai; Shinya Uchida; Mutsuhiro Ikuma; Shizuo Yamada; Hiroshi Watanabe; Akira Hishida; Takahisa Furuta
Journal:  Eur J Clin Pharmacol       Date:  2009-02-24       Impact factor: 2.953

10.  MDR1 polymorphisms have an impact on the prognosis of Chinese diffuse large B cell lymphoma patients.

Authors:  Ying Ni; Guangli Yin; Zhengrui Xiao; Lei Fan; Li Wang; Yujie Wu; Hanxin Wu; Sixuan Qian; Wei Xu; Jianyong Li; Kourong Miao; Hairong Qiu
Journal:  Tumour Biol       Date:  2015-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.